123 related articles for article (PubMed ID: 8448536)
1. Gene transfer and bone marrow transplantation with special reference to Gaucher's disease.
Karlsson S; Correll PH; Xu L
Bone Marrow Transplant; 1993; 11 Suppl 1():124-7. PubMed ID: 8448536
[TBL] [Abstract][Full Text] [Related]
2. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
Xu L; Stahl SK; Dave HP; Schiffmann R; Correll PH; Kessler S; Karlsson S
Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
[TBL] [Abstract][Full Text] [Related]
3. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
Wells S; Malik P; Pensiero M; Kohn DB; Nolta JA
Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601
[TBL] [Abstract][Full Text] [Related]
4. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
[TBL] [Abstract][Full Text] [Related]
5. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
Fabrega S; Lehn P
J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
[TBL] [Abstract][Full Text] [Related]
6. Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells.
Weinthal J; Nolta JA; Yu XJ; Lilley J; Uribe L; Kohn DB
Bone Marrow Transplant; 1991 Nov; 8(5):403-12. PubMed ID: 1768976
[TBL] [Abstract][Full Text] [Related]
7. Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA.
Nimgaonkar MT; Bahnson AB; Boggs SS; Ball ED; Barranger JA
Gene Ther; 1994 May; 1(3):201-7. PubMed ID: 7584082
[TBL] [Abstract][Full Text] [Related]
8. Long-term expression of the glucocerebrosidase gene in mouse and human hematopoietic progenitors.
Nimgaonkar M; Bahnson A; Kemp A; Lancia J; Mannion-Henderson J; Boggs S; Mohney T; Baysal B; Dunigan J; Barranger JA
Leukemia; 1995 Oct; 9 Suppl 1():S38-42. PubMed ID: 7475311
[TBL] [Abstract][Full Text] [Related]
9. Transduction of CD34+ enriched cord blood and Gaucher bone marrow cells by a retroviral vector carrying the glucocerebrosidase gene.
Bahnson AB; Nimgaonkar M; Fei Y; Boggs SS; Robbins PD; Ohashi T; Dunigan J; Li J; Ball ED; Barranger JA
Gene Ther; 1994 May; 1(3):176-84. PubMed ID: 7584079
[TBL] [Abstract][Full Text] [Related]
10. Development of safe and efficient retroviral vectors for Gaucher disease.
Havenga M; Fisher R; Hoogerbrugge P; Roberts B; Valerio D; van Es HH
Gene Ther; 1997 Dec; 4(12):1393-400. PubMed ID: 9472564
[TBL] [Abstract][Full Text] [Related]
11. Long-term expression of the human glucocerebrosidase gene in vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector.
Kim EY; Hong YB; Lai Z; Cho YH; Brady RO; Jung SC
J Gene Med; 2005 Jul; 7(7):878-87. PubMed ID: 15712335
[TBL] [Abstract][Full Text] [Related]
12. Cytokine mobilization of peripheral blood stem cells in patients with Gaucher disease with a view to gene therapy.
Nimgaonkar M; Mierski J; Beeler M; Kemp A; Lancia J; Mannion-Henderson J; Mohney T; Bahnson A; Rice E; Ball ED
Exp Hematol; 1995 Dec; 23(14):1633-41. PubMed ID: 8542958
[TBL] [Abstract][Full Text] [Related]
13. Efficient retroviral mediated transfer of the glucocerebrosidase gene in CD34+ enriched umbilical cord blood human hematopoietic progenitors.
Mannion-Henderson J; Kemp A; Mohney T; Nimgaonkar M; Lancia J; Beeler MT; Mierski J; Bahnson AB; Ball ED; Barranger JA
Exp Hematol; 1995 Dec; 23(14):1628-32. PubMed ID: 8542957
[TBL] [Abstract][Full Text] [Related]
14. [Molecular diagnosis and gene therapy for Gaucher disease].
Ohashi T
Nihon Rinsho; 1993 Sep; 51(9):2300-7. PubMed ID: 8411706
[TBL] [Abstract][Full Text] [Related]
15. A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients.
Medin JA; Migita M; Pawliuk R; Jacobson S; Amiri M; Kluepfel-Stahl S; Brady RO; Humphries RK; Karlsson S
Blood; 1996 Mar; 87(5):1754-62. PubMed ID: 8634421
[TBL] [Abstract][Full Text] [Related]
16. Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector.
Kiem HP; McSweeney PA; Bruno B; Goerner M; Buron G; Morris J; Storb R; Miller AD
Gene Ther; 1999 Jun; 6(6):966-72. PubMed ID: 10455398
[TBL] [Abstract][Full Text] [Related]
17. Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.
Fink JK; Correll PH; Perry LK; Brady RO; Karlsson S
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2334-8. PubMed ID: 2315324
[TBL] [Abstract][Full Text] [Related]
18. Bone-marrow transplantation in severe Gaucher's disease.
Rappeport JM; Ginns EI
N Engl J Med; 1984 Jul; 311(2):84-8. PubMed ID: 6377066
[TBL] [Abstract][Full Text] [Related]
19. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
[TBL] [Abstract][Full Text] [Related]
20. Production of human glucocerebrosidase in mice after retroviral gene transfer into multipotential hematopoietic progenitor cells.
Correll PH; Fink JK; Brady RO; Perry LK; Karlsson S
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8912-6. PubMed ID: 2573069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
